Company registration number 03935855 (England and Wales)
TRANSMEDICA LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2025
PAGES FOR FILING WITH REGISTRAR
TRANSMEDICA LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 6
TRANSMEDICA LIMITED
BALANCE SHEET
AS AT
28 FEBRUARY 2025
28 February 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Investment property
3
650,000
1,400,000
Current assets
Debtors falling due after more than one year
4
-
0
33,997
Debtors falling due within one year
4
1,536
1,348
Cash at bank and in hand
80,678
5,661
82,214
41,006
Creditors: amounts falling due within one year
5
(56,830)
(175,311)
Net current assets/(liabilities)
25,384
(134,305)
Total assets less current liabilities
675,384
1,265,695
Creditors: amounts falling due after more than one year
6
(625,947)
(717,420)
Provisions for liabilities
-
0
(105,719)
Net assets
49,437
442,556
Capital and reserves
Called up share capital
7
2
2
Profit and loss reserves
49,435
442,554
Total equity
49,437
442,556
TRANSMEDICA LIMITED
BALANCE SHEET (CONTINUED)
AS AT
28 FEBRUARY 2025
28 February 2025
- 2 -

For the financial year ended 28 February 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 27 November 2025 and are signed on its behalf by:
J P Patel
Director
Company registration number 03935855 (England and Wales)
TRANSMEDICA LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2025
- 3 -
1
Accounting policies
Company information

Transmedica Limited is a private company limited by shares incorporated in England and Wales. The registered office is 112 Guildhall Street, Folkestone, Kent, CT20 1ES.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include investment properties at fair value. The principal accounting policies adopted are set out below.

1.2
Going concern

At the time of approving the financial statements, the company had sold further investment properties. The directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future due to their continued financial support.true

 

Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Investment properties

Investment property, which is property held to earn rentals and/or for capital appreciation, is initially recognised at cost, which includes the purchase cost and any directly attributable expenditure. Subsequently it is measured at fair value at the reporting end date. The surplus or deficit on revaluation is recognised in the profit and loss account.

1.4
Cash at bank and in hand

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.5
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

TRANSMEDICA LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 28 FEBRUARY 2025
1
Accounting policies
(Continued)
- 4 -
Impairment of financial assets

Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.

 

Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.

 

If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Derecognition of financial liabilities

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

1.6
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

TRANSMEDICA LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 28 FEBRUARY 2025
- 5 -
2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
0
0
3
Investment property
2025
£
Fair value
At 29 February 2024
1,400,000
Additions
35,460
Disposals
(198,424)
Revaluations
(587,036)
At 28 February 2025
650,000

Investment property comprises of commercial properties with a fair value of £650,000. The fair value of the investment property has been determined by reference to the open market value basis by reference to market evidence of transaction prices for similar properties.

4
Debtors
2025
2024
Amounts falling due within one year:
£
£
Other debtors
1,536
1,348
2025
2024
Amounts falling due after more than one year:
£
£
Other debtors
-
0
33,997
Total debtors
1,536
35,345
5
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans
10,112
128,341
Trade creditors
43,184
45,032
Other creditors
3,534
1,938
56,830
175,311
TRANSMEDICA LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 28 FEBRUARY 2025
5
Creditors: amounts falling due within one year
(Continued)
- 6 -

The bank loans are secured by a fixed and floating charge over the company's assets.

6
Creditors: amounts falling due after more than one year
2025
2024
£
£
Bank loans
3,762
13,956
Other creditors
622,185
703,464
625,947
717,420

The bank loans are secured by a fixed and floating charge over the company's assets.

 

7
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of £1 each
2
2
2
2
8
Non-distributable profits reserve
2025
2024
£
£
At the beginning of the year
693,223
661,094
Non distributable profits in the year
(587,036)
32,129
At the end of the year
106,187
693,223
9
Directors' transactions

Included within other creditors are interest free loans from the directors amounting to £622,185 (2024: £690,595).

2025-02-282024-02-29falsefalsefalse27 November 2025CCH SoftwareCCH Accounts Production 2025.300No description of principal activityJ P PatelDr J P PatelR PatelJ P Patel039358552024-02-292025-02-28039358552025-02-28039358552024-02-2803935855core:Non-currentFinancialInstrumentscore:AfterOneYear2025-02-2803935855core:Non-currentFinancialInstrumentscore:AfterOneYear2024-02-2803935855core:WithinOneYear2025-02-2803935855core:WithinOneYear2024-02-2803935855core:AfterOneYear2025-02-2803935855core:AfterOneYear2024-02-2803935855core:CurrentFinancialInstruments2025-02-2803935855core:CurrentFinancialInstruments2024-02-2803935855core:Non-currentFinancialInstruments2025-02-2803935855core:Non-currentFinancialInstruments2024-02-2803935855core:ShareCapital2025-02-2803935855core:ShareCapital2024-02-2803935855core:RetainedEarningsAccumulatedLosses2025-02-2803935855core:RetainedEarningsAccumulatedLosses2024-02-2803935855core:ShareCapitalOrdinaryShareClass12025-02-2803935855core:ShareCapitalOrdinaryShareClass12024-02-2803935855bus:CompanySecretaryDirector12024-02-292025-02-28039358552023-03-012024-02-28039358552024-02-2803935855core:CurrentFinancialInstrumentscore:WithinOneYear2025-02-2803935855core:CurrentFinancialInstrumentscore:WithinOneYear2024-02-2803935855bus:OrdinaryShareClass12024-02-292025-02-2803935855bus:OrdinaryShareClass12025-02-2803935855bus:OrdinaryShareClass12024-02-2803935855bus:PrivateLimitedCompanyLtd2024-02-292025-02-2803935855bus:FRS1022024-02-292025-02-2803935855bus:AuditExemptWithAccountantsReport2024-02-292025-02-2803935855bus:Director12024-02-292025-02-2803935855bus:Director22024-02-292025-02-2803935855bus:Director32024-02-292025-02-2803935855bus:CompanySecretary12024-02-292025-02-2803935855bus:SmallCompaniesRegimeForAccounts2024-02-292025-02-2803935855bus:FullAccounts2024-02-292025-02-28xbrli:purexbrli:sharesiso4217:GBP